文献速递眼底病与葡萄膜炎

人视网膜和脉络膜血管内皮细胞深度蛋白质组学分析鉴定血管生成和免疫蛋白:新型生物药物的潜在靶点

Angiogenic and Immunologic Proteins Identified by Deep Proteomic Profiling of Human Retinal and Choroidal Vascular Endothelial Cells: Potential Targets for New Biologic Drugs.
PubMed 文献 · Am J Ophthalmol · 2018-03-17

研究从5对人眼配对样本中分别分离视网膜和脉络膜血管内皮细胞,采用反相液相色谱串联质谱和光谱计数进行深度蛋白质组学分析。共鉴定出5042个非冗余蛋白,在3454个可定量蛋白中498个(14.4%)差异表达(错误发现率0.05)。视网膜和脉络膜内皮细胞均富集血管生成蛋白,视网膜内皮细胞还富集免疫蛋白,为后节眼病提供了候选药物靶点。

要点

  • 人视网膜和脉络膜血管内皮细胞共表达5042个非冗余蛋白。
  • 3454个可定量蛋白中498个(14.4%)在两种内皮细胞间差异表达(错误发现率0.05)。
  • 两种内皮细胞均富集血管生成蛋白,视网膜内皮细胞还富集免疫蛋白。

核心结论

  • 本研究描述了人视网膜和脉络膜血管内皮细胞不同的蛋白质表达谱,为后节眼病的新型治疗或药物靶点提供了多个候选分子供进一步研究。

研究设计与样本

  • 从5对人眼配对样本中通过CD31选择分别分离视网膜和脉络膜血管内皮细胞,提取总蛋白并酶解,肽段经反相液相色谱串联质谱分析,通过光谱计数确定蛋白丰度,并使用公开软件包鉴定差异表达蛋白。

主要发现

  • 人视网膜和/或脉络膜血管内皮细胞表达5042个非冗余蛋白。
  • 将差异表达错误发现率设为0.05,在3454个可定量蛋白中,498个蛋白(14.4%)在两种细胞群体间差异丰度,最低平均光谱计数为2.5。
  • 视网膜和脉络膜内皮细胞均富集血管生成蛋白,视网膜内皮细胞还富集免疫蛋白。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Diseases that involve retinal or choroidal vascular endothelial cells are leading causes of vision loss: age-related macular degeneration, retinal ischemic vasculopathies, and noninfectious posterior uveitis. Proteins differentially expressed by these endothelial cell populations are potential drug targets. We used deep proteomic profiling to define the molecular phenotype of human retinal and choroidal endothelial cells at the protein level. METHODS: Retinal and choroidal vascular endothelial cells were separately isolated from 5 human eye pairs by selection on CD31. Total protein was extracted and digested, and peptide fractions were analyzed by reverse-phase liquid chromatography tandem mass spectrometry. Peptide sequences were assigned to fragment ion spectra, and proteins were inferred from openly accessible protein databases. Protein abundance was determined by spectral counting. Publicly available software packages were used to identify proteins that were differentially expressed between human retinal and choroidal endothelial cells, and to classify proteins that were highly abundant in each endothelial cell population. RESULTS: Human retinal and/or choroidal vascular endothelial cells expressed 5042 nonredundant proteins. Setting the differential expression false discovery rate at 0.05, 498 proteins of 3454 quantifiable proteins (14.4%) with minimum mean spectral counts of 2.5 were differentially abundant in the 2 cell populations. Retinal and choroidal endothelial cells were enriched in angiogenic proteins, and retinal endothelial cells were also enriched in immunologic proteins. CONCLUSIONS: This work describes the different protein expression profiles of human retinal and choroidal vascular endothelial cells, and provides multiple candidates for further study as novel treatments or drug targets for posterior eye diseases. NOTE: Publication of this article is sponsored by the American Ophthalmological Society.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Smith JR, David LL, Appukuttan B, et al. Angiogenic and Immunologic Proteins Identified by Deep Proteomic Profiling of Human Retinal and Choroidal Vascular Endothelial Cells: Potential Targets for New Biologic Drugs. Am J Ophthalmol. 2018. PMID: 29559410. doi:10.1016/j.ajo.2018.03.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。